188 related articles for article (PubMed ID: 27790710)
1. A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of C/EBPβ and OCT1 complex to chromatin.
Wu S; Wang S; Fu Y; Tang W; Jin H; Meng Q; Zhang C; Cui M; Cao X; Li X; Zhang Z; Chen R
Int J Cancer; 2017 Feb; 140(4):756-763. PubMed ID: 27790710
[TBL] [Abstract][Full Text] [Related]
2. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.
Huang D; Xiao J; Deng X; Ma K; Liang H; Shi D; Wu F; Shao Z
BMC Musculoskelet Disord; 2018 May; 19(1):137. PubMed ID: 29734947
[TBL] [Abstract][Full Text] [Related]
3. FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin.
Wang S; Wu S; Meng Q; Li X; Zhang J; Chen R; Wang M
Sci Rep; 2016 Jan; 6():19229. PubMed ID: 26759270
[TBL] [Abstract][Full Text] [Related]
4. Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.
Wang M; Wang Z; Wang XJ; Jin TB; Dai ZM; Kang HF; Guan HT; Ma XB; Liu XH; Dai ZJ
Drug Des Devel Ther; 2016; 10():2359-67. PubMed ID: 27524883
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms rs763110 in
Huang P; Wang CH; Zhuo LY; Xia XS; Yang S; Zhang JW; Fan HZ; Wu JJ; Yu R; Yue M; Zhang Y
Br J Biomed Sci; 2020 Jul; 77(3):112-117. PubMed ID: 32209020
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.
Hashemi M; Fazaeli A; Ghavami S; Eskandari-Nasab E; Arbabi F; Mashhadi MA; Taheri M; Chaabane W; Jain MV; Łos MJ
PLoS One; 2013; 8(1):e53075. PubMed ID: 23326385
[TBL] [Abstract][Full Text] [Related]
7. Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.
Rehman S; Saba N; Naz M; Ahmed P; Munir S; Sajjad S; Tabassum S; Naseem L
Immunol Invest; 2018 Jul; 47(5):484-491. PubMed ID: 29611722
[TBL] [Abstract][Full Text] [Related]
8. Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.
Zhu A; Wang M; Zhou G; Zhang H; Liu R; Wang Y
Rheumatol Int; 2016 Jun; 36(6):807-18. PubMed ID: 26905515
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
10. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
[TBL] [Abstract][Full Text] [Related]
11. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
Zhang M; Wu C; Li B; Du W; Zhang C; Chen Z
Cancer Med; 2016 Apr; 5(4):760-6. PubMed ID: 26819081
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
[TBL] [Abstract][Full Text] [Related]
15. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
Zhang W; Li C; Wang J; He C
Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
[TBL] [Abstract][Full Text] [Related]
16. Fas and FasL polymorphisms are not associated with acute myeloid leukemia risk in Koreans.
Kim HJ; Jin XM; Kim HN; Lee IK; Park KS; Park MR; Jo DY; Won JH; Kwak JY; Kim HJ; Choi JS; Juhng SW; Choi C
DNA Cell Biol; 2010 Oct; 29(10):619-24. PubMed ID: 20438363
[TBL] [Abstract][Full Text] [Related]
17. Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects.
Yu X; Li Y; Yu Y; Lei J; Wan G; Cao F
Onco Targets Ther; 2016; 9():2049-56. PubMed ID: 27103831
[TBL] [Abstract][Full Text] [Related]
18. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
Daripally S; Nallapalle SR; Katta S; Prasad VV
Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
